Next Article in Journal
Real-Life Use Patterns of Androgen Receptor Pathway Inhibitors (ARPIs): A Nationwide Register-Based Study in Finland During 2012–2023
Previous Article in Journal
Microengineered Breast Cancer Models: Shaping the Future of Personalized Oncology
Previous Article in Special Issue
Venetoclax–Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview
 
 
Article

Article Versions Notes

Cancers 2025, 17(19), 3161; https://doi.org/10.3390/cancers17193161
Action Date Notes Link
article xml file uploaded 29 September 2025 11:19 CEST Original file -
article xml uploaded. 29 September 2025 11:19 CEST Update https://www.mdpi.com/2072-6694/17/19/3161/xml
article pdf uploaded. 29 September 2025 11:19 CEST Version of Record https://www.mdpi.com/2072-6694/17/19/3161/pdf
article html file updated 29 September 2025 11:21 CEST Original file https://www.mdpi.com/2072-6694/17/19/3161/html
Back to TopTop